Lab-developed tests finally to come under US FDA regulatory scrutiny
This article was originally published in Clinica
Executive Summary
The US FDA has issued its much-awaited proposal on regulating laboratory-developed tests (LDTs), subjecting them - for the first time - to the agency's pre- and post-market requirements.